These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1049 related items for PubMed ID: 18068306

  • 21. Enhanced suppression of adrenocorticotropic hormone and cortisol responses to hypothalamic-pituitary-adrenal function and thyrotropin-releasing hormone tests after stressful life events in patients with major depressive disorder.
    Hikichi T, Akiyoshi J, Ichioka S, Tanaka Y, Tsuru J, Goto S, Matsushita H, Hanada H, Isogawa K, Nagayama H.
    Neuropsychobiology; 2007; 55(1):21-7. PubMed ID: 17556849
    [Abstract] [Full Text] [Related]

  • 22. Lithium, arginine vasopressin and the dex/CRH test in mood disordered patients.
    Watson S, Gallagher P, Smith MS, Young AH, Ferrier IN.
    Psychoneuroendocrinology; 2007 Jun; 32(5):464-9. PubMed ID: 17442500
    [Abstract] [Full Text] [Related]

  • 23. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L, Oquendo MA, Burke AK, Cooper TB, Mann JJ.
    J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
    [Abstract] [Full Text] [Related]

  • 24. The influence of psychiatric comorbidity on the dexamethasone/CRH test in major depression.
    Veen G, Derijk RH, Giltay EJ, van Vliet IM, van Pelt J, Zitman FG.
    Eur Neuropsychopharmacol; 2009 Jun; 19(6):409-15. PubMed ID: 19327969
    [Abstract] [Full Text] [Related]

  • 25. The thyrotropin-releasing hormone test may predict recurrence of clinical depression within ten years after discharge.
    Tsuru J, Ishitobi Y, Ninomiya T, Kanehisa M, Imanaga J, Inoue A, Okamoto S, Maruyama Y, Higuma H, Tanaka Y, Hanada H, Isogawa K, Akiyoshi J.
    Neuro Endocrinol Lett; 2013 Jun; 34(5):409-17. PubMed ID: 23922049
    [Abstract] [Full Text] [Related]

  • 26. Higher overcommitment to work is associated with higher plasma cortisol but not ACTH responses in the combined dexamethasone/CRH test in apparently healthy men and women.
    Wirtz PH, Siegrist J, Schuhmacher A, Hoefels S, Maier W, Zobel AW.
    Psychoneuroendocrinology; 2010 May; 35(4):536-43. PubMed ID: 19818562
    [Abstract] [Full Text] [Related]

  • 27. Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: dopaminergic, noradrenergic and thyroid correlates.
    Duval F, Mokrani MC, Monreal-Ortiz JA, Fattah S, Champeval C, Schulz P, Macher JP.
    Psychoneuroendocrinology; 2006 Aug; 31(7):876-88. PubMed ID: 16769179
    [Abstract] [Full Text] [Related]

  • 28. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions.
    Aihara M, Ida I, Yuuki N, Oshima A, Kumano H, Takahashi K, Fukuda M, Oriuchi N, Endo K, Matsuda H, Mikuni M.
    Psychiatry Res; 2007 Aug 15; 155(3):245-56. PubMed ID: 17587554
    [Abstract] [Full Text] [Related]

  • 29. Long-term outcome after lithium augmentation in unipolar depression: focus on HPA system activity.
    Adli M, Bschor T, Bauer M, Lucka C, Lewitzka U, Ising M, Uhr M, Mueller-Oerlinghausen B, Baethge C.
    Neuropsychobiology; 2009 Aug 15; 60(1):23-30. PubMed ID: 19684420
    [Abstract] [Full Text] [Related]

  • 30. Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression.
    Pfennig A, Kunzel HE, Kern N, Ising M, Majer M, Fuchs B, Ernst G, Holsboer F, Binder EB.
    Biol Psychiatry; 2005 Feb 15; 57(4):336-42. PubMed ID: 15705348
    [Abstract] [Full Text] [Related]

  • 31. HPA axis functioning associated with transition to psychosis: combined DEX/CRH test.
    Thompson KN, Berger G, Phillips LJ, Komesaroff P, Purcell R, McGorry PD.
    J Psychiatr Res; 2007 Aug 15; 41(5):446-50. PubMed ID: 16403528
    [Abstract] [Full Text] [Related]

  • 32. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
    Petrowski K, Wintermann GB, Kirschbaum C, Bornstein SR.
    Psychoneuroendocrinology; 2012 Aug 15; 37(8):1199-208. PubMed ID: 22277728
    [Abstract] [Full Text] [Related]

  • 33. Simultaneous use of thyrotropin-releasing hormone test and combined dexamethasone/corticotropine-releasing hormone test for severity evaluation and outcome prediction in patients with major depressive disorder.
    Isogawa K, Nagayama H, Tsutsumi T, Kiyota A, Akiyoshi J, Hieda K.
    J Psychiatr Res; 2005 Sep 15; 39(5):467-73. PubMed ID: 15992555
    [Abstract] [Full Text] [Related]

  • 34. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.
    Bschor T, Baethge C, Adli M, Eichmann U, Ising M, Uhr M, Müller-Oerlinghausen B, Bauer M.
    Depress Anxiety; 2003 Sep 15; 17(1):43-8. PubMed ID: 12577277
    [Abstract] [Full Text] [Related]

  • 35. Cortisol responses to combined dexamethasone/CRH test in outpatients with a major depressive episode.
    Gervasoni N, Bertschy G, Osiek C, Perret G, Denis R, Golaz J, Rossier MF, Bondolfi G, Aubry JM.
    J Psychiatr Res; 2004 Sep 15; 38(6):553-7. PubMed ID: 15458850
    [Abstract] [Full Text] [Related]

  • 36. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
    Esel E, Kartalci S, Tutus A, Turan T, Sofuoglu S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar 15; 28(2):303-9. PubMed ID: 14751427
    [Abstract] [Full Text] [Related]

  • 37. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
    Ströhle A.
    Nervenarzt; 2003 Mar 15; 74(3):279-91; quiz 292. PubMed ID: 12627245
    [Abstract] [Full Text] [Related]

  • 38. [Function of the hypothalamo-hypophyseal-adrenal axis to corticotropin-releasing hormone test in premature infants with bronchopulmonary dysplasia].
    Merz U, Pfäffle R, Peschgens T, Hörnchen H.
    Z Geburtshilfe Neonatol; 1997 Mar 15; 201(6):253-7. PubMed ID: 9491545
    [Abstract] [Full Text] [Related]

  • 39. Social support and enhanced suppression of adrenocorticotropic hormone and cortisol responses to hypothalamic-pituitary-adrenal function and thyrotropin-releasing hormone tests in patients with major depressive disorder.
    Tsuru J, Akiyoshi J, Tanaka Y, Matsushita H, Hanada H, Kodama K, Hikichi T, Ohgami H, Tsutsumi T, Isogawa K, Nagayama H.
    Biol Psychol; 2008 May 15; 78(2):159-63. PubMed ID: 18359551
    [Abstract] [Full Text] [Related]

  • 40. High neuroticism and depressive temperament are associated with dysfunctional regulation of the hypothalamic-pituitary-adrenocortical system in healthy volunteers.
    Zobel A, Barkow K, Schulze-Rauschenbach S, Von Widdern O, Metten M, Pfeiffer U, Schnell S, Wagner M, Maier W.
    Acta Psychiatr Scand; 2004 May 15; 109(5):392-9. PubMed ID: 15049775
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 53.